Growth Metrics

Invivyd (IVVD) Profit After Tax (2021 - 2025)

Invivyd posted quarterly Profit After Tax of -$11.1 million for Q4 2025, up 39.92% year-on-year from -$7.9 million in Q4 2024, and down 5.84% on a QoQ basis from -$10.5 million in Q3 2025.

Invivyd (IVVD) has 5 years of Profit After Tax data on file, last reported at -$11.1 million in Q4 2025.

  • For the quarter ending Q4 2025, Profit After Tax rose 39.92% year-over-year to -$11.1 million; the trailing twelve-month figure through Dec 2025 stood at -$52.5 million (up 69.1% YoY), and the FY2025 full-year result was -$52.5 million, up 69.1% from the prior year.
  • Profit After Tax for Q4 2025 stood at -$11.1 million, down from -$10.5 million in the prior quarter.
  • Across five years, Profit After Tax topped out at -$10.5 million in Q3 2025 and bottomed at -$100.7 million in Q1 2022.
  • The 5-year median for Profit After Tax is -$44.6 million (2021), against an average of -$44.5 million.
  • The widest annual swing landed in 2022, when Profit After Tax tumbled 160.12%; it then surged 82.76% in 2025.
  • A 5-year view of Profit After Tax shows it stood at -$83.0 million in 2021, then surged by 46.32% to -$44.6 million in 2022, then slumped by 65.24% to -$73.7 million in 2023, then soared by 74.96% to -$18.4 million in 2024, then surged by 39.92% to -$11.1 million in 2025.
  • The last three Profit After Tax figures came in at -$11.1 million (Q4 2025), -$10.5 million (Q3 2025), and -$14.7 million (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) PAT (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -2.99 Mn
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 30.90 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -14.46 Mn
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 1.03 Bn
7 Evaxion A 62.56 Bn 62.54 Bn - -3.63 Mn
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 727.20 Mn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 205.99 Mn
10 Invivyd 208.38 Mn -18.31 Mn - -11.08 Mn

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 -11.08 Mn
Sep 30, 2025 -10.47 Mn
Jun 30, 2025 -14.66 Mn
Mar 31, 2025 -16.29 Mn
Dec 31, 2024 -18.44 Mn
Sep 30, 2024 -60.74 Mn
Jun 30, 2024 -47.25 Mn
Mar 31, 2024 -43.50 Mn
Dec 31, 2023 -73.65 Mn
Sep 30, 2023 -39.44 Mn
Jun 30, 2023 -50.23 Mn
Mar 31, 2023 -35.32 Mn
Dec 31, 2022 -44.57 Mn
Sep 30, 2022 -45.09 Mn
Jun 30, 2022 -50.99 Mn
Mar 31, 2022 -100.67 Mn
Dec 31, 2021 -83.04 Mn
Sep 30, 2021 -60.38 Mn
Jun 30, 2021 -44.67 Mn
Mar 31, 2021 -38.70 Mn